Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Change in Intangibles (2020 - 2025)

Historic Change in Intangibles for Harvard Bioscience (HBIO) over the last 5 years, with Q3 2025 value amounting to $141000.0.

  • Harvard Bioscience's Change in Intangibles fell 3896.1% to $141000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $620000.0, marking a year-over-year decrease of 948.91%. This contributed to the annual value of $619000.0 for FY2024, which is 1835.56% up from last year.
  • Per Harvard Bioscience's latest filing, its Change in Intangibles stood at $141000.0 for Q3 2025, which was down 3896.1% from $144000.0 recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Change in Intangibles registered a high of $231000.0 during Q4 2023, and its lowest value of $75000.0 during Q1 2024.
  • Its 4-year average for Change in Intangibles is $158818.2, with a median of $150000.0 in 2021.
  • Within the past 5 years, the most significant YoY rise in Harvard Bioscience's Change in Intangibles was 12666.67% (2025), while the steepest drop was 3896.1% (2025).
  • Over the past 4 years, Harvard Bioscience's Change in Intangibles (Quarter) stood at $150000.0 in 2021, then skyrocketed by 54.0% to $231000.0 in 2023, then fell by 28.57% to $165000.0 in 2024, then decreased by 14.55% to $141000.0 in 2025.
  • Its last three reported values are $141000.0 in Q3 2025, $144000.0 for Q2 2025, and $170000.0 during Q1 2025.